Hematology

ELEVATED markers of blood clotting have been attributed to the persistent symptoms of Long COVID, such as reduced physical fitness and…

Predicting individual patient response, as well as progressing understanding of new therapies in development, may be improved by the use of a newly developed 3D bone marrow model.

Balancing risk of adverse reactions against the protection of effective vaccination is a hotly debated topic in the current phase of the global response to the COVID-19 pandemic. Rare blood clot reactions have been of particular concern, and a recently published case report shares the first successful treatment of a vaccine-induced thrombosis reaction.

YELODYSPLASTIC syndrome (MDS) is a disorder that disrupts the maturation and differentiation of haematopoietic stem cells in the bone marrow.

PROMISING results of a newly advanced chimeric antigen receptor (CAR) T-cell therapy showed that more than triple the period remission for multiple myeloma.

While many new immunotherapies are increasing cancer survival rates, tools to predict how the immunotherapy will impact a patient’s immune system are not…

Hospitalisation of patients with sickle cell disease (SCD) who have coronavirus disease (COVID-19) is reported to be notably higher than the average…

ACTIVATION of T cells within lymph nodes is an important component of effective immunity, but recent research has shown that this activation may be…